Cargando…

Serial exome analysis of disease progression in premalignant gammopathies

Detalles Bibliográficos
Autores principales:	Zhao, Siming, Choi, Murim, Heuck, Christoph, Mane, Shrikant, Barlogie, Bart, Lifton, Richard P., Dhodapkar, Madhav V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142199/ https://www.ncbi.nlm.nih.gov/pubmed/24496302 http://dx.doi.org/10.1038/leu.2014.59

Ejemplares similares

Vigorous Premalignancy-specific Effector T Cell Response in the Bone Marrow of Patients with Monoclonal Gammopathy
por: Dhodapkar, Madhav V., et al.
Publicado: (2003)

A Reversible Defect in Natural Killer T Cell Function Characterizes the Progression of Premalignant to Malignant Multiple Myeloma
por: Dhodapkar, Madhav V., et al.
Publicado: (2003)

Frequent and specific immunity to the embryonal stem cell–associated antigen SOX2 in patients with monoclonal gammopathy
por: Spisek, Radek, et al.
Publicado: (2007)

Flow cytometry defined cytoplasmic immunoglobulin index is a major prognostic factor for progression of asymptomatic monoclonal gammopathies to multiple myeloma (subset analysis of SWOG S0120)
por: Papanikolaou, X, et al.
Publicado: (2016)

Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy
por: Robinson, M. Hope, et al.
Publicado: (2023)

Application of Whole Exome Sequencing to Identify Disease-Causing Variants in Inherited Human Diseases
por: Goh, Gerald, et al.
Publicado: (2012)

B-Cell-Specific Myd88 L252P Expression Causes a Premalignant Gammopathy Resembling IgM MGUS
por: Schmidt, Kristin, et al.
Publicado: (2020)

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
por: Krauthammer, Michael, et al.
Publicado: (2012)

On optimal pooling designs to identify rare variants through massive resequencing
por: Lee, Joon Sang, et al.
Publicado: (2011)

Whole exome sequencing identifies recessive WDR62 mutations in severe brain malformations
por: Bilgüvar, Kaya, et al.
Publicado: (2010)

Whole exome sequencing reveals somatic mutations in HRAS and KRAS which cause nevus sebaceus
por: Levinsohn, Jonathan L., et al.
Publicado: (2012)

Exome Sequencing Links Mutations in PARN and RTEL1 with Familial Pulmonary Fibrosis and Telomere Shortening
por: Stuart, Bridget D., et al.
Publicado: (2015)

Oral Premalignancy
por: Hume, W.
Publicado: (1981)

Moving Immunoprevention Beyond Virally Mediated Malignancies: Do We Need to Link It to Early Detection?
por: Dhodapkar, Madhav V., et al.
Publicado: (2019)

Evaluation of mast cells in oral premalignant and malignant lesions: A histochemical study
por: Singh, Shreya, et al.
Publicado: (2018)

Monoclonal gammopathies
por: Tozzi, S
Publicado: (2010)

Beyond DNA: the Role of Epigenetics in the Premalignant Progression of Breast Cancer
por: DeVaux, Rebecca S., et al.
Publicado: (2018)

Macrophages promote the progression of premalignant mammary lesions to invasive cancer
por: Carron, Emily C., et al.
Publicado: (2017)

Stromal Gas6 promotes the progression of premalignant mammary cells
por: Gomes, Angelica M., et al.
Publicado: (2018)

Inferring early genetic progression in cancers with unobtainable premalignant disease
por: Leshchiner, Ignaty, et al.
Publicado: (2023)

Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical use
por: van Laar, Ryan, et al.
Publicado: (2014)

Are Hepatic Adenomas Premalignant?
por: Nagorney, David M.
Publicado: (1996)

Premalignant conditions of bone
por: Horvai, Andrew, et al.
Publicado: (2006)

Premalignant Lesions in the Kidney
por: Kirkali, Ziva, et al.
Publicado: (2001)

Premalignant Conditions of Bone
por: Eckhoff, Michael D., et al.
Publicado: (2022)

Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosis
por: Papanikolaou, Xenofon, et al.
Publicado: (2014)

Whole-Exome Sequencing of Germline Variants in Non-BRCA Families with Hereditary Breast Cancer
por: Liu, Yaxuan, et al.
Publicado: (2022)

Transcriptional regulation by normal epithelium of premalignant to malignant progression in Barrett’s esophagus
por: Zeng, Jia, et al.
Publicado: (2016)

Role of IL-23 signaling in the progression of premalignant oral lesions to cancer
por: Caughron, Blaine, et al.
Publicado: (2018)

Transcriptomic analysis predicts the risk of progression of premalignant lesions in human tongue
por: Zhang, Tuo, et al.
Publicado: (2023)

The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance
por: Castillo, Jorge J., et al.
Publicado: (2021)

Co-evolution of Immune Response in Multiple Myeloma: Implications for Immune Prevention
por: McCachren, Samuel S., et al.
Publicado: (2021)

Immunostimulation and Immunoinhibition of Premalignant Lesions
por: Prehn, Richmond T
Publicado: (2007)

Premalignant male genital dermatoses
por: Singhal, Rochit Rajesh, et al.
Publicado: (2019)

Natural Killer T Cells in Cancer Immunotherapy
por: Nair, Shiny, et al.
Publicado: (2017)

Genomics and premalignant breast lesions: clues to the development and progression of lobular breast cancer
por: Mastracci, Teresa L, et al.
Publicado: (2007)

Progress risk assessment of oral premalignant lesions with saliva miRNA analysis
por: Yang, Ya, et al.
Publicado: (2013)

Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions
por: Beane, Jennifer E., et al.
Publicado: (2019)

Oncolytic Herpes Simplex Virus Prevents Premalignant Lesions from Progressing to Cancer
por: Woo, Yanghee, et al.
Publicado: (2019)

Urine proteomic signatures predicting the progression from premalignancy to malignant gastric cancer
por: Fan, Hua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5ujgds43q6v64k1o5f97md2gmj